Detalles de la búsqueda
1.
Long-Term Pooled Safety Analysis of Palbociclib in Combination with Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Updated Analysis with up to 5 Years of Follow-Up.
Oncologist
; 26(5): e749-e755, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33486783
2.
Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.
Breast J
; 26(3): 368-375, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31448513
3.
Palbociclib with Letrozole in Postmenopausal Women with ER+/HER2- Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA-2 Trial.
Oncologist
; 24(12): 1514-1525, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31217344
4.
Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2- Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate.
Clin Drug Investig
; 43(9): 699-706, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37594640
5.
Progression-free Survival Outcome Is Independent of Objective Response in Patients With Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer Treated With Palbociclib Plus Letrozole Compared With Letrozole: Analysis From PALOMA-2.
Clin Breast Cancer
; 20(2): e173-e180, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31836434
6.
Long-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer.
J Natl Cancer Inst
; 111(4): 419-430, 2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30032196
7.
Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study.
J Glob Oncol
; 5: 1-19, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31125276
8.
Correction: Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2- Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate.
Clin Drug Investig
; 43(9): 707-708, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37695417
Resultados
1 -
8
de 8
1
Próxima >
>>